Joffe & Associés advised GENEO Capital Entrepreneur on its acquisition of a stake in Lodigroup, a French industrial company specialising in biosecurity and building protection.
Founded in 1981, Lodigroup is a recognised player in public health that develops, manufactures and markets solutions to control pests, preserve stored goods and protect buildings. In particular, its products and services are intended for pest control applicators, farmers and agri-food operators, local authorities and building tradespeople.
Lodigroup has seven locations in France and the United Kingdom, including three industrial sites in Brittany and Normandy. The group, active in more than 35 countries, employs over 160 people and generated revenue of more than €70 million in 2025.
Led by GENEO Capital Entrepreneur and BNP Paribas Développement, the transaction aims to support a new phase of growth for the group, particularly in Europe, through targeted acquisitions and a sustained commitment to innovation.
This transaction reflects the GENEO approach: providing hands-on support to business leaders by jointly building a growth trajectory in the service of a sustainable entrepreneurial project.
For this transaction, the Joffe & Associés team was composed of Aymeric Dégremont and Romain Soiron, partners.